Researchers are excited about the medication , a groundbreaking dual agonist showing significant results in initial trials for weight loss . It acts by modulating several pathways : GLP-1 and GIP, that , https://adrianaxxts457879.blogchaat.com/41055744/this-new-hope-for-size-reduction